Qianwang Ma
Tianjin, 300211, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.
NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.
Journal: Discover oncology
Published: June 26, 2024
Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization.
Journal: Frontiers in genetics
Published: February 28, 2024
YAP is required for prostate development, regeneration, and prostate stem cell function.
Journal: Cell death discovery
Published: June 06, 2023
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
Journal: Cell death & disease
Published: September 28, 2022
Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.
Journal: Frontiers in genetics
Published: September 17, 2021
Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3.
Journal: Journal of Cancer
Published: April 01, 2021
A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy.
Journal: Translational andrology and urology
Published: March 15, 2021
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
Journal: NPJ precision oncology
Published: July 02, 2020
Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer.
Journal: Journal of Cancer
Published: June 16, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026